Company / Cash & Equivalents
SkinHealth Systems Inc. Cash & Equivalents History
FY2021-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$568.2M
FY2022
5-year range
$568.2M / $901.9M
FY2021-FY2022
Trend
-37.0%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$568M in FY2022.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, cash & equivalents decreased 37.0% year-over-year.
Company context
Key Data Points
- Altman Z-Score 0.21 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $568.2M | -37.0% |
| FY2021 | $901.9M | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026